Ferlay , Bray F, Pisani P, Parkin D: GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. 2001, IARC Press
Google Scholar
Silverman DT, Devessa SS, Moore LF, Rothman N: Bladder cancer. Cancer Epidemiology and Prevention. 2005
Google Scholar
Volkmer BG, Seidl-Schlick EM, Bach D, Romics I, Kleinschmidt K: Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma. Clin Rheumatol. 2005, 24 (4): 319-323. 10.1007/s10067-004-1032-2.
Article
PubMed
Google Scholar
IARC: Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. 1987, Lyon: International Agency for Research on Cancer, 7:
Google Scholar
McCredie M, Stewart JH, Ford JM, MacLennan RA: Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Uurol. 1983, 55 (2): 220-224.
Article
CAS
Google Scholar
Piper JM, Tonascia J, Matanoski GM: Heavy phenacetin use and bladder cancer in women aged 20 to 49 years. N Engl J Med. 1985, 313 (5): 292-295.
Article
CAS
PubMed
Google Scholar
Fokkens W: Phenacetin abuse related to bladder cancer. Environ Res. 1979, 20 (1): 192-198. 10.1016/0013-9351(79)90097-5.
Article
CAS
PubMed
Google Scholar
Castelao JE, Yuan JM, Gago-Dominguez M, Yu MC, Ross RK: Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br J Cancer. 2000, 82 (7): 1364-1369. 10.1054/bjoc.1999.1106.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC: Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer. 1999, 81 (3): 542-548. 10.1038/sj.bjc.6690728.
Article
CAS
PubMed
PubMed Central
Google Scholar
McCredie M, Stewart JH: Does paracetamol cause urothelial cancer or renal papillary necrosis?. Nephron. 1988, 49 (4): 296-300.
Article
CAS
PubMed
Google Scholar
Pommer W, Bronder E, Klimpel A, Helmert U, Greiser E, Molzahn M: Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant. 1999, 14 (12): 2892-2897. 10.1093/ndt/14.12.2892.
Article
CAS
PubMed
Google Scholar
Steffens J, Nagel R: Tumours of the renal pelvis and ureter. Observations in 170 patients. Br J Urol. 1988, 61 (4): 277-283.
Article
CAS
PubMed
Google Scholar
Derby LE, Jick H: Acetaminophen and renal and bladder cancer. Epidemiology. 1996, 7 (4): 358-362. 10.1097/00001648-199607000-00004.
Article
CAS
PubMed
Google Scholar
Friis S, Nielsen GL, Mellemkjaer L, McLaughlin JK, Thulstrup AM, Blot WJ, Lipworth L, Vilstrup H, Olsen JH: Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study. Int J Cancer. 2002, 97 (1): 96-101. 10.1002/ijc.1581.
Article
CAS
PubMed
Google Scholar
Kaye JA, Myers MW, Jick H: Acetaminophen and the risk of renal and bladder cancer in the general practice research database. Epidemiology. 2001, 12 (6): 690-694. 10.1097/00001648-200111000-00018.
Article
CAS
PubMed
Google Scholar
Kreiger N, Marrett LD, Dodds L, Hilditch S, Darlington GA: Risk factors for renal cell carcinoma: results of a population-based case-control study. Cancer Causes Control. 1993, 4 (2): 101-110. 10.1007/BF00053150.
Article
CAS
PubMed
Google Scholar
McCredie M, Pommer W, McLaughlin JK, Stewart JH, Lindblad P, Mandel JS, Mellemgaard A, Schlehofer B, Niwa S: International renal-cell cancer study. II. Analgesics. Int J Cancer. 1995, 60 (3): 345-349.
Article
CAS
PubMed
Google Scholar
McCredie M, Stewart JH, Day NE: Different roles for phenacetin and paracetamol in cancer of the kidney and renal pelvis. Int J Cancer. 1993, 53 (2): 245-249. 10.1002/ijc.2910530212.
Article
CAS
PubMed
Google Scholar
Rosenberg L, Rao RS, Palmer JR, Strom BL, Zauber A, Warshauer ME, Stolley PD, Shapiro S: Transitional cell cancer of the urinary tract and renal cell cancer in relation to acetaminophen use (United States). Cancer Causes Control. 1998, 9 (1): 83-88. 10.1023/A:1008805505154.
Article
CAS
PubMed
Google Scholar
Langman MJ, Cheng KK, Gilman EA, Lancashire RJ: Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database. BMJ. 2000, 320 (7250): 1642-1646. 10.1136/bmj.320.7250.1642.
Article
CAS
PubMed
PubMed Central
Google Scholar
Paganini-Hill A, Chao A, Ross RK, Henderson BE: Aspirin use and chronic diseases: a cohort study of the elderly. BMJ. 1989, 299 (6710): 1247-1250.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rao KV, Detrisac CJ, Steele VE, Hawk ET, Kelloff GJ, McCormick DL: Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder. Carcinogenesis. 1996, 17 (7): 1435-1438. 10.1093/carcin/17.7.1435.
Article
CAS
PubMed
Google Scholar
Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E: Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res. 2004, 24 (5B): 3177-3184.
PubMed
Google Scholar
Sorensen HT, Friis S, Norgard B, Mellemkjaer L, Blot WJ, McLaughlin JK, Ekbom A, Baron JA: Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer. 2003, 88 (11): 1687-1692. 10.1038/sj.bjc.6600945.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW: Aspirin use and risk of fatal cancer. Cancer Res. 1993, 53 (6): 1322-1327.
CAS
PubMed
Google Scholar
Kelsey KT, Hirao T, Schned A, Hirao S, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR: A population-based study of immunohistochemical detection of p53 alteration in bladder cancer. Br J Cancer. 2004, 90 (8): 1572-1576. 10.1038/sj.bjc.6601748.
Article
CAS
PubMed
PubMed Central
Google Scholar
West SL, Savitz DA, Koch G, Strom BL, Guess HA, Hartzema A: Recall accuracy for prescription medications: self-report compared with database information. Am J Epidemiol. 1995, 142 (10): 1103-1112.
CAS
PubMed
Google Scholar
Fortuny J, Kogevinas M, Garcia-Closas M, Real FX, Tardon A, Garcia-Closas R, Serra C, Carrato A, Lloreta J, Rothman N, et al: Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain. Cancer Epidemiol Biomarkers Prev. 2006, 15 (9): 1696-1702. 10.1158/1055-9965.EPI-06-0038.
Article
CAS
PubMed
Google Scholar
Mancini F, Landolfi C, Muzio M, Aquilini L, Soldo L, Coletta I, Guglielmotti A, Mantovani A, Pinza M, Milanese C: Acetaminophen down-regulates interleukin-1beta-induced nuclear factor-kappaB nuclear translocation in a human astrocytic cell line. Neurosci Lett. 2003, 353 (2): 79-82. 10.1016/j.neulet.2003.08.074.
Article
CAS
PubMed
Google Scholar
Xie DH, Tang XD, Xia SJ, Tan JM, Wang XH, Cai Y: [Expression of NF-kappa B in human bladder cancer and its clinical significance]. Ai Zheng. 2002, 21 (6): 663-667.
PubMed
Google Scholar
Ruepp SU, Tonge RP, Shaw J, Wallis N, Pognan F: Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci. 2002, 65 (1): 135-150. 10.1093/toxsci/65.1.135.
Article
CAS
PubMed
Google Scholar
de Morais SM, Uetrecht JP, Wells PG: Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome. Gastroenterology. 1992, 102 (2): 577-586.
Article
CAS
PubMed
Google Scholar
Takada Y, Bhardwaj A, Potdar P, Aggarwal BB: Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene. 2004, 23 (57): 9247-9258.
CAS
PubMed
Google Scholar
Wulfing C, Eltze E, Von Struensee D, Wulfing P, Bode ME, Bettendorf O, Piechota H, Hertle L: [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications]. Aktuelle Urol. 2004, 35 (4): 331-338. 10.1055/s-2004-818537.
Article
CAS
PubMed
Google Scholar
Brown JR, DuBois RN: COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol. 2005, 23 (12): 2840-2855. 10.1200/JCO.2005.09.051.
Article
CAS
PubMed
Google Scholar
Wild PJ, Kunz-Schughart LA, Stoehr R, Burger M, Blaszyk H, Simon R, Gasser T, Mihatsch M, Sauter G, Hartmann A: High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer. Int J Oncol. 2005, 27 (2): 385-391.
CAS
PubMed
Google Scholar
Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE: Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005, 294 (1): 47-55. 10.1001/jama.294.1.47.
Article
CAS
PubMed
Google Scholar
Schreinemachers DM, Everson RB: Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology. 1994, 5 (2): 138-146. 10.1097/00001648-199403000-00003.
Article
CAS
PubMed
Google Scholar